Featured Product
This Week in Quality Digest Live
FDA Compliance Features
Etienne Nichols
What’s the difference?
Liza Dzhezhora
How to ensure the integration of IoMT devices in your practice
Del Williams
Options to address the risk of combustible dust explosions for NFPA 61 compliance
Doug Folsom
Unpatched vulnerabilities will become increasingly susceptible to cyberattacks
Del Williams
Mitigate risk, prevent safety issues by utilizing closed conveyor systems designed with sanitation in mind

More Features

FDA Compliance News
Creates one of the most comprehensive regulatory SaaS platforms for the industry
Company’s first funding round will be used to accelerate product development for its QMS and MES SaaS offerings
Showcasing tech, solutions, and services at Gulfood Manufacturing 2022
Easy, reliable leak testing with methylene blue
Now is not the time to skip critical factory audits and supply chain assessments
Google Docs collaboration, more efficient management of quality deviations
Delivers time, cost, and efficiency savings while streamlining compliance activity
First trial module of learning tool focuses on ISO 9001 and is available now
Free education source for global medical device community

More News

Quality Digest

FDA Compliance

Study Identifies Pharmaceutical Launch Best Practices

Published: Tuesday, May 24, 2005 - 22:00

A recent benchmarking study examines best practices in pharmaceutical launches, and includes case studies and insights from some of the industry’s biggest companies.The study, performed by Best Practices LLC, includes best practices from Merck & Co., Eli Lilly & Co., Wyeth, GlaxoSmithKline Inc., Novartis, Johnson & Johnson and AstraZeneca. “Best Practices in Global Pharmaceutical Launches” includes:
  • Analysis of the multiyear marketing launch investment and expense patterns of successful products
  • Profiles of leading pharmaceutical companies’ approaches to structuring global marketing organizations
  • Identification of best management practices employed during key launch activities
  • Key lessons learned in planning and coordinating successful global product launches

The leading practices, managerial insights and benchmark metrics in the report are drawn from in-depth surveys and interviews with more than 26 executives at leading pharmaceutical companies. The project team used the launches of 12 pharmaceutical products, including Zoloft, Paxil, Cardizem, Fosamax and Lipitor, to illustrate some of the problems the companies faced.

For more information, visit www3.best-in-class.com.


About The Author

Quality Digest’s picture

Quality Digest

For 40 years Quality Digest has been the go-to source for all things quality. Our newsletter, Quality Digest, shares expert commentary and relevant industry resources to assist our readers in their quest for continuous improvement. Our website includes every column and article from the newsletter since May 2009 as well as back issues of Quality Digest magazine to August 1995. We are committed to promoting a view wherein quality is not a niche, but an integral part of every phase of manufacturing and services.